Statins for Cardiovascular Prevention According to Different Strategies: A Cost Analysis

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.11, Iss.1, 2011-02, pp. : 33-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statins for the Primary Prevention of Cardiovascular Disease in the Elderly

The Consultant Pharmacist, Vol. 30, Iss. 1, 2015-01 ,pp. : 20-30

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Beyond the Statins: New Therapeutic Perspectives in Cardiovascular Disease Prevention

By Chapman M.

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 2, 2005-03 ,pp. : 135-139

Springer Publishing Company

Access to resources Recommend Favorite

Lipid Management Strategies for the Prevention of Adverse Cardiovascular Events

Heart Drug, Vol. 2, Iss. 4, 2002-11 ,pp. : 159-161

Karger

Access to resources Recommend Favorite

Cost-Effective Strategies in the Prevention of Diabetic Nephropathy

By Rippin J.D. Barnett A.H. Bain S.C.

PharmacoEconomics, Vol. 22, Iss. 1, 2004-01 ,pp. : 9-28

Adis International

Access to resources Recommend Favorite

Primary prevention strategies for lipid-lowering: cost effectiveness

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 575, 2009-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite